Skip to main content
Top
Published in: Abdominal Radiology 2/2017

01-02-2017 | Pictorial Essay

Artificial ascites and pneumoperitoneum to facilitate thermal ablation of liver tumors: a pictorial essay

Authors: Sharath K. Bhagavatula, Jeffrey F. B. Chick, Nikunj R. Chauhan, Paul B. Shyn

Published in: Abdominal Radiology | Issue 2/2017

Login to get access

Abstract

Image-guided percutaneous thermal ablation is increasingly utilized in the treatment of hepatic malignancies. Peripherally located hepatic tumors can be difficult to access or located adjacent to critical structures that can be injured. As a result, ablation of peripheral tumors may be avoided or may be performed too cautiously, leading to inadequate ablation coverage. In these cases, separating the tumor from adjacent critical structures can increase the efficacy and safety of procedures. Artificial ascites and artificial pneumoperitoneum are techniques that utilize fluid and gas, respectively, to insulate critical structures from the thermal ablation zone. Induction of artificial ascites and artificial pneumoperitoneum can enable complete ablation of otherwise inaccessible hepatic tumors, improve tumor visualization, minimize unintended thermal injury to surrounding organs, and reduce post-procedural pain. This pictorial essay illustrates and discusses the proper technique and clinical considerations for successful artificial ascites and pneumoperitoneum creation to facilitate safe peripheral hepatic tumor ablation.
Literature
1.
go back to reference Livraghi T, Solbiati L, Meloni MF, et al. (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study 1. Radiology 226:441–451CrossRefPubMed Livraghi T, Solbiati L, Meloni MF, et al. (2003) Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study 1. Radiology 226:441–451CrossRefPubMed
2.
go back to reference Solbiati L, Livraghi T, Goldberg SN, et al. (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221(1):159–166CrossRefPubMed Solbiati L, Livraghi T, Goldberg SN, et al. (2001) Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 221(1):159–166CrossRefPubMed
3.
go back to reference Curley SA, Izzo F, Delrio P, et al. (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230(1):1–8CrossRefPubMedPubMedCentral Curley SA, Izzo F, Delrio P, et al. (1999) Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 230(1):1–8CrossRefPubMedPubMedCentral
4.
go back to reference Kim Y-S, Lee WJ, Rhim H, et al. (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195(September):758–765CrossRefPubMed Kim Y-S, Lee WJ, Rhim H, et al. (2010) The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (>2 and <5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 195(September):758–765CrossRefPubMed
5.
go back to reference Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188(2):480–488CrossRefPubMed Nakazawa T, Kokubu S, Shibuya A, et al. (2007) Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin. AJR Am J Roentgenol 188(2):480–488CrossRefPubMed
6.
go back to reference Wood TF, Rose DM, Chung M, et al. (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7(8):593–600CrossRefPubMed Wood TF, Rose DM, Chung M, et al. (2000) Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 7(8):593–600CrossRefPubMed
7.
go back to reference Lee EJ, Rhim H, Lim HK, et al. (2008) Effect of artificial ascites on thermal injury to the diaphragm and stomach in radiofrequency ablation of the liver: experimental study with a porcine model. AJR Am J Roentgenol 190(6):1659–1664. http://www.ncbi.nlm.nih.gov/pubmed/18492921. Accessed 27 Nov 2014 Lee EJ, Rhim H, Lim HK, et al. (2008) Effect of artificial ascites on thermal injury to the diaphragm and stomach in radiofrequency ablation of the liver: experimental study with a porcine model. AJR Am J Roentgenol 190(6):1659–1664. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​18492921. Accessed 27 Nov 2014
9.
go back to reference Koda M, Maeda Y, Matsunaga Y, et al. (2004) Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. Am J Roentgenol 183(3):583–588CrossRef Koda M, Maeda Y, Matsunaga Y, et al. (2004) Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. Am J Roentgenol 183(3):583–588CrossRef
12.
go back to reference Yamakado K, Nakatsuka A, Akeboshi M, Takeda K (2003) Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol 14(9 Pt 1):1183–1186CrossRefPubMed Yamakado K, Nakatsuka A, Akeboshi M, Takeda K (2003) Percutaneous radiofrequency ablation of liver neoplasms adjacent to the gastrointestinal tract after balloon catheter interposition. J Vasc Interv Radiol 14(9 Pt 1):1183–1186CrossRefPubMed
14.
go back to reference Song I, Rhim H, Lim HK, Kim Y-S, Choi D (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19(11):2630–2640. http://www.ncbi.nlm.nih.gov/pubmed/19557416. Accessed 14 Dec 2014 Song I, Rhim H, Lim HK, Kim Y-S, Choi D (2009) Percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the diaphragm and gastrointestinal tracts with the use of artificial ascites: safety and technical efficacy in 143 patients. Eur Radiol 19(11):2630–2640. http://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​19557416. Accessed 14 Dec 2014
18.
20.
go back to reference Nishimura M, Nouso K, Kariyama K, et al. (2012) Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma. Acta Med Okayama 66(3):279–284PubMed Nishimura M, Nouso K, Kariyama K, et al. (2012) Safety and efficacy of radiofrequency ablation with artificial ascites for hepatocellular carcinoma. Acta Med Okayama 66(3):279–284PubMed
21.
go back to reference Raman SS, Lu DSK, Vodopich DJ, Sayre J, Lassman C (2002) Minimizing Diaphragmatic Injury during radio-frequency ablation: efficacy of subphrenic peritoneal saline injection in a porcine model 1. Radiology 9:819–823CrossRef Raman SS, Lu DSK, Vodopich DJ, Sayre J, Lassman C (2002) Minimizing Diaphragmatic Injury during radio-frequency ablation: efficacy of subphrenic peritoneal saline injection in a porcine model 1. Radiology 9:819–823CrossRef
22.
go back to reference Raman SS, Sayre J, Lu D, et al. (2004) Minimizing diaphragmatic injury during radiofrequency ablation : efficacy of intraabdominal carbon dioxide insufflation. AJR Am J Roentgenol 183:197–200CrossRefPubMed Raman SS, Sayre J, Lu D, et al. (2004) Minimizing diaphragmatic injury during radiofrequency ablation : efficacy of intraabdominal carbon dioxide insufflation. AJR Am J Roentgenol 183:197–200CrossRefPubMed
23.
24.
go back to reference Brace CL (2009) Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences. Curr Probl Diagn Radiol 38(3):135–143CrossRefPubMedPubMedCentral Brace CL (2009) Radiofrequency and microwave ablation of the liver, lung, kidney, and bone: what are the differences. Curr Probl Diagn Radiol 38(3):135–143CrossRefPubMedPubMedCentral
25.
go back to reference Blaser A, Roset P (1999) Fatal carbon dioxide embolism as an unreported complication of retroperitoneoscopy. Surg Endosc 13(7):713–714CrossRefPubMed Blaser A, Roset P (1999) Fatal carbon dioxide embolism as an unreported complication of retroperitoneoscopy. Surg Endosc 13(7):713–714CrossRefPubMed
26.
go back to reference Lantz P, Smith J (1994) Fatal carbon dioxide embolism complicating attempted laparoscopic cholecystectomy–case report and literature review. J Forensic Sci 39(6):1468–1480CrossRefPubMed Lantz P, Smith J (1994) Fatal carbon dioxide embolism complicating attempted laparoscopic cholecystectomy–case report and literature review. J Forensic Sci 39(6):1468–1480CrossRefPubMed
27.
go back to reference Berberoglu M, Dilek ON, Ercan F, Kati I, Ozmen M (1998) The effect of CO2 insufflation rate on the postlaparoscopic shoulder pain. J Laparoendosc Adv Surg Tech 8(5):273–277CrossRef Berberoglu M, Dilek ON, Ercan F, Kati I, Ozmen M (1998) The effect of CO2 insufflation rate on the postlaparoscopic shoulder pain. J Laparoendosc Adv Surg Tech 8(5):273–277CrossRef
Metadata
Title
Artificial ascites and pneumoperitoneum to facilitate thermal ablation of liver tumors: a pictorial essay
Authors
Sharath K. Bhagavatula
Jeffrey F. B. Chick
Nikunj R. Chauhan
Paul B. Shyn
Publication date
01-02-2017
Publisher
Springer US
Published in
Abdominal Radiology / Issue 2/2017
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0910-9

Other articles of this Issue 2/2017

Abdominal Radiology 2/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.